CAS 1134613-19-6

CW 008

Description:

CW 008, identified by its CAS number 1134613-19-6, is a chemical compound that falls under the category of synthetic compounds. While specific characteristics such as its molecular structure, physical properties, and reactivity may not be widely documented in public databases, compounds like CW 008 are often studied for their potential applications in various fields, including pharmaceuticals, materials science, or chemical research. Typically, such substances may exhibit unique properties such as specific solubility, stability under certain conditions, and reactivity with other chemicals. The safety profile, including toxicity and environmental impact, is also crucial for understanding its handling and usage. For detailed information, including its synthesis, applications, and safety data, consulting specialized chemical literature or databases is recommended. Always ensure to follow safety guidelines and regulations when working with any chemical substance.

Formula: C₂₁H₁₄F₂N₆O₂

Synonyms:

• 4-Fluoro-N-[5-fluoro-6-(5-methoxypyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-b]pyridin-3-yl]benzamide
• Benzamide, 4-fluoro-N-[5-fluoro-6-(5-methoxypyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-
• CW 008

CW 008

CAS: 1134613-19-6

CW 008

Purity: ≥95%

Ref: 54-BUP22575

CW 008

CAS: 1134613-19-6

CW 008 is a pharmaceutical compound that has shown to be an inhibitor of cancer stem cells and their ability to induce apoptosis. It also prevents autophagy, which is a process of self-eating that cancer cells use to survive. CW 008 has been shown to inhibit activin, which are proteins that are known for their teratogenic effects on the ovary and other tissues. CW 008's effect on meiotic cells is not yet clear, but it does not seem to have any effect on culturing human embryonic stem cells.
CW 008 was first discovered in the 1990s when it was found to be a potent inhibitor of leukemia cells in mice. This discovery led to further investigation into its properties as an anticancer agent and its potential applications in chemotherapy.

Formula: C₂₁H₁₄F₂N₆O₂

Purity: Min. 95%

Molecular weight: 420.4 g/mol

Ref: 3D-JVB61319

CW 008

CAS: 1134613-19-6

CW 008 is an agonist of the cAMP/PKA/CREB pathway, promoting osteogenic differentiation of bone marrow-derived mesenchymal stem cells (MSCs).a PKA activator.

Formula: C₂₁H₁₄F₂N₆O₂

Purity: 97.39%

Color and Shape: Solid

Molecular weight: 420.37

Ref: TM-T31124